ANDOVER, Mass., May 02, 2018 -- Omnify Software, a leading provider of web-based Product Lifecycle Management (PLM) software for discrete manufacturers, along with their client, BionX Medical, now Ottobock, the leading global supplier of mechatronic prosthetic and orthotic devices, has been selected as a finalist for the 2018 Medical Design Excellence Awards (MDEA) for the design and development of the Empower prosthetic foot.
Now in its 20th year, the MDEA is the premier awards program for the medtech industry. The awards program celebrates the accomplishments of medical device manufacturers, their suppliers, and the many people behind the scenes—engineers, scientists, designers, and clinicians—who are responsible for the cutting-edge products that are saving lives. They are improving patient healthcare and transforming medtech—one innovation at a time. Omnify was recognized as Ottobock’s PLM supplier helping the company meet time to market, compliance and efficiency goals for a major re-design of the world’s only active prosthetic foot. The Empower is an innovation in the field of prosthetic feet and is equipped with an active ankle joint, making it the only prosthetic foot with powered propulsion.
"We are honored to be recognized for the MDEA alongside our customer," stated Chuck Cimalore, CTO for Omnify Software. "A growing number of medtech companies have adopted our PLM solution to help design safe, innovative, and compliant products and it is great to see our customers recognized for their product achievements."
The 2018 winners will be announced at the MDEA Ceremony on Tuesday, June 12, 2018 in conjunction with the MD&M East event, organized by UBM, taking place at the Jacob K. Javits Convention Center in New York. To learn more about the event please visit: www.MDMeast.com
About Omnify Software
Omnify Software, the leading provider of business-ready Product Lifecycle Management (PLM) solutions for discrete manufacturers, helps OEMs shorten development cycles, accelerate product innovation and improve bottom-line profitability. Omnify's commitment to customer success has resulted in a unique solution that is quick to implement, easy to use, and provides an open integration platform to easily share data with engineering and business systems. Our web-based technology offers flexible deployment options that allow customers to deploy on-premises, in the cloud or via a hybrid approach. Omnify is well-known for superior customer service, delivering outstanding training, development and support with a team of experienced technology professionals. For more information about Omnify Software Product Lifecycle Management, please call 978-988-3800, email [email protected], visit www.omnifysoft.com, or follow us on LinkedIn, Twitter, Facebook or YouTube.
About Ottobock
Ottobock Healthcare develops and pioneers medical technology products and treatment concepts for people with limited mobility in the areas of Prosthetics, Orthotics, Human Mobility (wheelchairs, rehabilitation devices) and MedicalCare. With subsidiaries in more than 50 countries, Ottobock offers “Best in Class” quality worldwide, and employs more than 7,000 team members. A family-managed company since its founding in 1919, Ottobock has also been supporting the Paralympic Games with its technical expertise since 1988.
"Omnify" is a registered trademark of Omnify Software. Any trade, product or service name referenced in this document using the name "Omnify" is a trademark and/or property of Omnify Software. All other trade, product, or service names referenced in this release may be trademarks or registered trademarks of their respective holders.”
Media Contact:
Alaine Portnoy
Omnify Software
[email protected]
978-988-3800
Valerie Harding
Ripple Effect Communications
[email protected]
617-536-8887


Trump’s Approval of AI Chip Sales to China Triggers Bipartisan National Security Concerns
Samsung SDI Secures Major LFP Battery Supply Deal in the U.S.
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs
CVS Health Signals Strong 2026 Profit Outlook Amid Turnaround Progress
Rio Tinto Signs Interim Agreement With Yinhawangka Aboriginal Group Over Pilbara Mining Operations
ADB Approves $400 Million Loan to Boost Ease of Doing Business in the Philippines
Microsoft Unveils Massive Global AI Investments, Prioritizing India’s Rapidly Growing Digital Market
Gulf Sovereign Funds Unite in Paramount–Skydance Bid for Warner Bros Discovery
SoftBank Shares Slide as Oracle’s AI Spending Plans Fuel Market Jitters
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute
SpaceX Edges Toward Landmark IPO as Elon Musk Confirms Plans
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
Nvidia Develops New Location-Verification Technology for AI Chips
Moore Threads Stock Slides After Risk Warning Despite 600% Surge Since IPO
Westpac Director Peter Nash Avoids Major Investor Backlash Amid ASX Scrutiny
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand 



